262 related articles for article (PubMed ID: 16130187)
1. Dose requirements of continuous infusion of rocuronium and atracurium throughout orthotopic liver transplantation in humans.
Weng XC; Zhou L; Fu YY; Zhu SM; He HL; Wu J
J Zhejiang Univ Sci B; 2005 Sep; 6(9):869-72. PubMed ID: 16130187
[TBL] [Abstract][Full Text] [Related]
2. Dose requirements of vecuronium, pancuronium, and atracurium during orthotopic liver transplantation.
O'Kelly B; Jayais P; Veroli P; Lhuissier C; Ecoffey C
Anesth Analg; 1991 Dec; 73(6):794-8. PubMed ID: 1683184
[TBL] [Abstract][Full Text] [Related]
3. Infusion requirements and reversibility of rocuronium at the corrugator supercilii and adductor pollicis muscles.
Suzuki T; Mizutani H; Miyake E; Fukano N; Saeki S; Ogawa S
Acta Anaesthesiol Scand; 2009 Nov; 53(10):1336-40. PubMed ID: 19650798
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the dose-response and time course of recovery of atracurium and rocuronium.
Xue F; Zhang Y; Liao X; Liu J; An G
Chin Med J (Engl); 2000 Nov; 113(11):1019-21. PubMed ID: 11776116
[TBL] [Abstract][Full Text] [Related]
5. The effect of isoflurane versus balanced anesthesia on rocuronium's pharmacokinetics and infusion requirement.
Larijani GE; Gratz I; Afshar M; McDonald PA; Fisher DM
Pharmacotherapy; 1995; 15(1):36-41. PubMed ID: 7739943
[TBL] [Abstract][Full Text] [Related]
6. Rocuronium infusion requirements and plasma concentrations at constant levels of neuromuscular paralysis during three phases of liver transplantation.
Gao L; Ramzan I; Baker B
J Clin Anesth; 2003 Jun; 15(4):257-66. PubMed ID: 12888160
[TBL] [Abstract][Full Text] [Related]
7. Cumulation characteristics of cisatracurium and rocuronium during continuous infusion.
Miller DR; Wherrett C; Hull K; Watson J; Legault S
Can J Anaesth; 2000 Oct; 47(10):943-9. PubMed ID: 11032267
[TBL] [Abstract][Full Text] [Related]
8. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure.
Della Rocca G; Pompei L; Coccia C; Costa MG; Cecchini V; Vilardi V; Pietropaoli P
Minerva Anestesiol; 2003; 69(7-8):605-11, 612, 5. PubMed ID: 14564242
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function.
Kopman AF; Kopman DJ; Ng J; Zank LM
J Clin Anesth; 2005 Feb; 17(1):30-5. PubMed ID: 15721727
[TBL] [Abstract][Full Text] [Related]
10. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia.
Rex C; Wagner S; Spies C; Scholz J; Rietbergen H; Heeringa M; Wulf H
Anesthesiology; 2009 Jul; 111(1):30-5. PubMed ID: 19512873
[TBL] [Abstract][Full Text] [Related]
11. Rocuronium profile during orthotopic liver transplantation: effect of changing the order of vascular clamp release at reperfusion of the hepatic graft.
Sabaté A; Ferreres E; Valcárcel M; Dalmau A; Koo M; Fabregat J
Transplant Proc; 2010 Jun; 42(5):1760-2. PubMed ID: 20620518
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of the effect of nitrous oxide on rocuronium infusion requirements using closed-loop feedback control.
Illman H; Antila H; Olkkola KT
Anesthesiology; 2008 Mar; 108(3):388-91. PubMed ID: 18292676
[TBL] [Abstract][Full Text] [Related]
13. Selection of neuromuscular blocking agents in patients undergoing renal transplantation under general anesthesia.
Ma H; Zhuang X
Chin Med J (Engl); 2002 Nov; 115(11):1692-6. PubMed ID: 12609090
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics and pharmacokinetics of rocuronium following continuous infusion in patients during intravenous anaesthesia.
Sparr HJ; Khuenl-Brady KS; Eriksson LI
Eur J Anaesthesiol Suppl; 1994; 9():63-5. PubMed ID: 7925211
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure.
Robertson EN; Driessen JJ; Vogt M; De Boer H; Scheffer GJ
Eur J Anaesthesiol; 2005 Dec; 22(12):929-32. PubMed ID: 16318664
[TBL] [Abstract][Full Text] [Related]
16. Recovery of neuromuscular block in morbidly obese patients following an infusion of rocuronium.
Spoelders K; van Duffel L; Vandermeersch E; Adriaenssens G; Van de Velde M
Acta Anaesthesiol Belg; 2001; 52(3):293-5. PubMed ID: 11732386
[No Abstract] [Full Text] [Related]
17. Pharmacokinetic-pharmacodynamic relationship of rocuronium under stable nitrous oxide-fentanyl or nitrous oxide-sevoflurane anesthesia in children.
Woloszczuk-Gebicka B; Wyska E; Grabowski T; Swierczewska A; Sawicka R
Paediatr Anaesth; 2006 Jul; 16(7):761-8. PubMed ID: 16879519
[TBL] [Abstract][Full Text] [Related]
18. Rocuronium bromide in the ICU: dose finding and pharmacokinetics.
Khuenl-Brady KS; Sparr H; Pühringer F; Agoston S
Eur J Anaesthesiol Suppl; 1995 Sep; 11():79-80. PubMed ID: 8557012
[TBL] [Abstract][Full Text] [Related]
19. Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis.
Woloszczuk-Gebicka B; Wyska E; Grabowski T
Paediatr Anaesth; 2007 Jul; 17(7):637-46. PubMed ID: 17564645
[TBL] [Abstract][Full Text] [Related]
20. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
